Visit the Cambridge Major Laboratories website
American Capital Commits $212 Million In The One Stop Buyout® Of Cambridge Major Laboratories, Inc.
Bethesda, MD - December 27, 2012 - American Capital, Ltd. (Nasdaq: ACAS) ("American Capital") announced today that it has committed $212 million in the One Stop Buyout® of Cambridge Major Laboratories, Inc. ("CML" or the "Company"), a leading global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML expands American Capital's portfolio of healthcare products and services companies, which have aggregate revenues of over $600 million1. American Capital's investment took the form of debt and preferred and common equity. Jefferies & Company, Inc., served as sole financial advisor to CML on the transaction. CML was a portfolio company of Arlington Capital Partners prior to American Capital's investment. [more]